Your browser doesn't support javascript.
loading
How do we ensure a safe ABO recheck process?
Stephens, Laura D; Allen, Elizabeth S; Bloch, Evan M; Crowe, Elizabeth P; Campbell-Lee, Sally A; Booth, Garrett S; Kopko, Patricia.
  • Stephens LD; University of California San Diego Health, La Jolla, California, USA.
  • Allen ES; University of California San Diego Health, La Jolla, California, USA.
  • Bloch EM; Johns Hopkins University School of Medicine Baltimore, Baltimore, Maryland, USA.
  • Crowe EP; Johns Hopkins University School of Medicine Baltimore, Baltimore, Maryland, USA.
  • Campbell-Lee SA; University of Illinois at Chicago, Chicago, Illinois, USA.
  • Booth GS; Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Kopko P; University of California San Diego Health, La Jolla, California, USA.
Transfusion ; 63(10): 1789-1796, 2023 10.
Article en En | MEDLINE | ID: mdl-37660311
ABSTRACT

BACKGROUND:

Collecting a patient's blood in a correctly labeled pretransfusion specimen tube is essential for accurate ABO typing and safe transfusion. Noncompliance with specimen collection procedures can lead to wrong blood in tube (WBIT) incidents with potentially fatal consequences. Recent WBIT events inspired the investigation of how various institutions currently reduce the risk of these errors and ensure accurate ABO typing of patient samples. MATERIALS AND

METHODS:

This article describes the techniques employed at various institutions across the United States to mitigate the risk of misidentified pretransfusion patient specimens. Details and considerations for each of these measures are provided.

RESULTS:

Several institutions require the order for an ABO confirmation specimen, if indicated, to be generated from the transfusion medicine (TM) laboratory. Others issue a dedicated collection tube that is available exclusively from the TM service. Many institutions employ barcoding for electronic positive patient identification. Some use a combination of these strategies, depending on the locations or service lines from which the specimens are collected.

CONCLUSION:

The description of various WBIT mitigation strategies will inform TM services on practices that may be effective at their respective institutions. Irrespective of the method(s) utilized, institutions should continue to monitor and mitigate specimen misidentification errors to promote sustained safe transfusion practices.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Transfusión Sanguínea / Errores Médicos Tipo de estudio: Prognostic_studies Límite: Humans País como asunto: America do norte Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Transfusión Sanguínea / Errores Médicos Tipo de estudio: Prognostic_studies Límite: Humans País como asunto: America do norte Idioma: En Año: 2023 Tipo del documento: Article